In CC Dr. Steiner reports "Selected Unaudited Combined (FHC & Aspen), Financial Highlights for the year ended September 2015"
Net Revenue $32.6 million dollars (see page 38 where I obtained this number on information for the merger)
Of which in the combined: Aspen's net revenue was $50,000 (Call Dr. Steiner if you want to confirm this number.)
and that means that FHC net revenue was $32,550,000
This way of reporting conceals the truth. What else is concealed or spun?
FHC will be the cash cow for an emerging speculative biopharma company. NO is the intelligent and only vote for the merger. FHC shares would be diluted and devalued.